论文部分内容阅读
目的:研究小儿支原体肺炎的临床疗效及治疗方案。方法:回顾分析60例小儿支原体肺炎病例。结果:60例患者中,发热患者48例,全部有咳嗽症状,没有显著阳性体征的有19例,运用ELISA(酶联免疫吸附试验)检测患者血清MP-IgM,阳性46例,占76.7%。全部病例通过阿奇霉素治疗之后,疗效显著,未出现肝肾损害患者。结论:小儿支原体肺炎多发于学龄儿童,运用ELISA检测血清MP-IgM的阳性率相当高,可以应用于前期诊断,运用阿齐霉素进行静脉滴注治疗,疗效安全确切。
Objective: To study the clinical efficacy and treatment of mycoplasma pneumonia in children. Methods: A retrospective analysis of 60 cases of children with mycoplasma pneumonia. Results: Of the 60 patients, 48 cases were fever, all had cough symptoms, 19 cases had no significant positive signs. Serum MP-IgM was detected by enzyme-linked immunosorbent assay (ELISA) in 46 cases (76.7%). After all the cases treated by azithromycin, the curative effect is remarkable, there is no liver and kidney damage patients. Conclusion: Mycoplasma pneumonia is more common in children of school age. The positive rate of serum MP-IgM detected by ELISA is quite high. It can be used in pre-diagnosis and treated with intravenous infusion of azithromycin. The curative effect is safe and accurate.